Effect of Tocilizumab Treatment on Seroconversion in Hyperinflammation Secondary to Covid 19

Aim:During the ongoing COVID-19 pandemic, the management of hyperinflammation, a serious symptom that occurs secondary to the disease, has emerged as a major challenge. Tocilizumab, an immunosuppressive drug, offers a potential solution. However, it is extremely important to understand its effects o...

Full description

Bibliographic Details

Published in:	Acta Medica Alanya
Main Authors:	Nilgün Işıksaçan, Hakan Koçoğlu, Ezgi Şahin, Deniz Yılmaz, Faruk Karandere, Felemez Arslan
Format:	Article
Language:	English
Published:	Alanya Alaaddin Keykubat University 2024-04-01
Subjects:	covid 19 il-6 hiperinflamasyon tocilizumab antikor covid-19 hyperinflammation antibody
Online Access:	https://dergipark.org.tr/tr/download/article-file/3758779